Sustained inhibition of experimental neointimal hyperplasia with a genetically modified herpes simplex virus (Q44452117)

3 December 2017

title

Sustained inhibition of experimental neointimal hyperplasia with a genetically modified herpes simplex virus (English)

1 reference

3 December 2017

8

Bernard Roizman

1 reference

3 December 2017

9

Ralph R Weichselbaum

1 reference

3 December 2017

Michael A Curi

1

1 reference

3 December 2017

Christopher L Skelly

2

1 reference

3 December 2017

Shari L Meyerson

3

1 reference

3 December 2017

Zachary K Baldwin

4

1 reference

3 December 2017

Viji Balasubramanian

5

1 reference

3 December 2017

Sunil J Advani

6

1 reference

3 December 2017

Seymour Glagov

7

1 reference

3 December 2017

Lewis B Schwartz

10

1 reference

3 December 2017

publication date

1 June 2003

1 reference

Journal of Vascular Surgery

3 December 2017

published in

1 reference

3 December 2017

volume

37

1 reference

3 December 2017

issue

6

1 reference

3 December 2017

page(s)

1294-1300

1 reference

The restenosis paradigm revisited: an alternative proposal for cellular mechanisms

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

The use of herpes simplex virus-based vectors for gene delivery to the nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Herpesvirus-mediated systemic delivery of nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Inhibition of rat vascular smooth muscle cell proliferation in vitro and in vivo by recombinant replication-competent herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Herpes simplex virus 1 gamma(1)34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Treatment of human renal cell carcinoma by a conditionally replicating herpes vector G207

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Adenoviral-mediated gene transfer in human and animal vein grafts using clinically relevant exposure times, pressures, and viral concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Adenoviral-mediated gene transfer of a constitutively active form of the retinoblastoma gene product attenuates neointimal thickening in experimental vein grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2802%2975333-0

7 January 2021

10.1016/S0741-5214(02)75333-0

Identifiers

DOI

1 reference

3 December 2017

1 reference